-
Zometa and hip fractures; Merck HIV Vaccine Ineffective in Clinical Trial; Thimerosal and Mercury Exposure; FDA Actions
-
-
This study examined outcomes in 50,322 patients admitted to the emergency department and later transferred to the ICU during the period from 2000-2003.
-
Upper gastrointestinal hemorrhage results in 250,000 hospitalizations and between 15,000 and 30,000 deaths per year in the United States.
-
-
Outcomes for treatment of stroke with intravenous tissue plasminogen activator (tPA) were similar at community hospitals supported by telemedicine consultation with stroke experts compared to academic stroke centers.
-
Long-term monitoring is likely to detect atrial fibrillation in stroke patients with frequent atrial premature beats.
-
The US FDA Adverse Event Reporting System (AERS) was searched for reports of nephrolithiasis in HIV patients receiving atazanavir (ATV)-containing antiretroviral (ARV) regimens; 30 cases were identified.
-
Withdrawal of statin therapy in acute ischemic stroke may lead to increases in death and disability.
-
Carcinoma of unknown primary remains a management problem without an established approach demonstrated to prolong survival. In a phase II study, the combination of carboplatin, gemcitabine, and capecitabine was shown to be fairly well tolerated and, for certain subsets, effective in producing transient tumor regression.
